E. coli Lipopolysaccharide: Acute oral toxicity study in mice

Food and Chemical Toxicology

Volumn 49, Issue 8, 2011, Pages 1770-1772

  Harper, Marc S ^a   Carpenter, Carol ^b   Klocke, D J ^c   Carlson, Gabrielle ^a   Davis, Tom ^a   Delaney, Bryan ^a  

^a PIONEER HI BRED INTERNATIONAL INC   (United States)

^b DUPONT COMPANY   (United States)

^c Aldevron LLC   (United States)

Author keywords

Acute; Endotoxin; Lipopolysaccharide; LPS; Mouse

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; EXPOSURE; FEMALE; MALE; MORTALITY; MOUSE; NONHUMAN; ORGAN INJURY; SURVIVAL RATE; TOXICITY TESTING; WEIGHT REDUCTION;

ACUTE TOXICITY TESTS; ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEMALE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR;

ESCHERICHIA COLI; MUS;

EID: 79958761273     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.04.025     Document Type: Article

References (26)

1. Berczi I., Baintner K., Antal T. Comparative assay of endotoxins by oral and parenteral administration. Zentralbl Veterinarmed B 1966, 13:570-575.
2. Birjmohun R.S., van Leuven S.I., Levels J.H., van 't Veer C., Kuivenhoven J.A., Meijers J.C., Levi M., Kastelein J.J., van der Poll T., Stroes E.S. High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1153-1158.
3. Brito L.A., Singh M. Acceptable levels of endotoxin in vaccine formulations during preclinical research. J. Pharm. Sci. 2011, 100:34-37.
4. Chen R.H., Huang C.J., Newton B.S., Ritter G., Old L.J., Batt C.A. Factors affecting endotoxin removal from recombinant therapeutic proteins by anion exchange chromatography. Protein Expr. Purif. 2009, 64:76-81.
5. Cognet I., de Coignac A.B., Magistrelli G., Jeannin P., Aubry J.P., Maisnier-Patin K., Caron G., Chevalier S., Humbert F., Nguyen T., Beck A., Velin D., Delneste Y., Malissard M., Gauchat J.F. Expression of recombinant proteins in a lipid a mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation. J. Immunol. Methods 2003, 272:199-210.
6. Delaney B., Zhang J., Carlson G., Schmidt J., Stagg B., Comstock B., Babb A., Finlay C., Cressman R.F., Ladics G., Cogburn A., Siehl D., Bardina L., Sampson H., Han Y. Gene-shuffled glyphosate acetyltransferase protein from Bacillus licheniformis (GAT4601) shows no evidence of allergenicity or toxicity. Toxicol. Sci. 2008, 102:425-432.
7. FDA. 1987. Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products, and Medical Devices. Center for Drug Evaluation and Research. Accessed 10/19/2010. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM080966.pdf.
8. Greisman S.E., Hornick R.B. Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin. Proc. Soc. Exp. Biol. Med. 1969, 131:1154-1158.
9. Harama D., Koyama K., Mukai M., Shimokawa N., Miyata M., Nakamura Y., Ohnuma Y., Ogawa H., Matsuoka S., Paton A.W., Paton J.C., Kitamura M., Nakao A. A subcytotoxic dose of subtilase cytotoxin prevents lipopolysaccharide-induced inflammatory responses, depending on its capacity to induce the unfolded protein response. J. Immunol. 2009, 183:1368-1374.
10. Liu S., Tobias R., McClure S., Styba G., Shi Q., Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin. Biochem. 1997, 30:455-463.
11. Magalhaes P.O., Lopes A.M., Mazzola P.G., Rangel -Y.C., Penna T.C., Pessoa A. Methods of endotoxin removal from biological preparations: a review. J. Pharm. Pharm. Sci. 2007, 10:388-404.
12. Mathesius C.A., Barnett J.F., Cressman R.F., Ding J., Carpenter C., Ladics G.S., Schmidt J., Layton R.J., Zhang J.X., Appenzeller L.M., Carlson G., Ballou S., Delaney B. Safety assessment of a modified acetolactate synthase protein (GM-HRA) used as a selectable marker in genetically modified soybeans. Regul. Toxicol. Pharmacol. 2009, 55:309-320.
13. Muller -L.S., Lindner B., Brade H. Structural analysis of oligosaccharides from lipopolysaccharide (LPS) of Escherichia coli K12 strain W3100 reveals a link between inner and outer core LPS biosynthesis. J. Biol. Chem. 2003, 5:34090-34101.
14. Oz H.S., Ebersole J.L. Application of prodrugs to inflammatory diseases of the gut. Molecules 2008, 27:452-474.
15. Petsch D., Anspach F.B. Endotoxin removal from protein solutions. J. Biotechnol. 2000, 76:97-119.
16. Quemada H., Zarka K., Pett W., Bothma G., Felcher K., Mirendil H., Koch M., Brink J., Douches D. Safety evaluations of the cry1Ia1 protein found in the transgenic potato 'SpuntaG2'. J. Am. Soc. Hort. Sci. 2010, 135:325-332.
17. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Padova di F., Schreier M., Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994, 8:217-225.
18. Somerville J.E., Cassiano L., Bainbridge B., Cunningham M.D., Darveau R.P. A novel Escherichia coli lipid a mutant that produces an anti-inflammatory lipopolysaccharide. J. Clin. Invest. 1996, 97:359-365.
19. Tenaillon O., Skurnik D., Picard B., Denamur E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 2010, 8:207-217.
20. Wakelin S.J., Sabroe I., Gregory C.D., Poxton I.R., Forsythe J.L., Garden O.J., Howie S.E. "Dirty little secrets" -endotoxin contamination of recombinant proteins. Immunol. Lett. 2006, 106:1-7.
21. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
22. Wang L., Wang Q., Reeves P.R. The variation of O antigens in gram-negative bacteria. Subcell. Biochem. 2010, 53:123-152.
23. Xia D., Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl. Acad. 1997, 94:2575-2580.
24. Xu W., Cao S., He X., Luo Y., Guo X., Yuan Y., Huang K. Safety assessment of Cry1Ab/Ac fusion protein. Food Chem. Toxicol. 2009, 47:1459-1465.
25. Yang Q., Zhou D., Sun L., Zhang D., Qian J., Xiong C., Sun Y., Ma L., Zhu C. Expression and characterization of two pesticide resistance-associated serine protease genes (NYD-tr and NYD-ch) from Culex pipiens pallens for metabolism of deltamethrin. Parasitol. Res. 2008, 103:507-516.
26. Youngner J.S. Bacterial lipopolysaccharide: oral route for interferon production in mice. Infect. Immun. 1972, 6:646-647.